Rnatives
1 known investors
Find your way into Rnatives
150 people in our graph share verified history with the Rnatives team — schools, employers, funds. One of them is your warm intro.
Gunnar Ahlbergunlockedknows Tiia Turunen · together at Karolinska Institutet (overlapped)
knows the team · via ImmunOs Therapeutics AG
×5knows the team · via Karolinska Institutet
×5knows the team · via University of Virginia School of Law
Develops precision RNA-based gene-regulating therapies aimed at treating serious diseases.
Founders & leadership
TT
Tiia TuruneninCDO, Co-founderTiia Turunen is Co-founder and CDO of Rnatives and has a research background in non-coding RNAs and gene expression regulation.
JA
Jeff AbbeyinCEOJeff Abbey is CEO of Rnatives and has previously led an oncology cell therapy company through phase 3 clinical development and toward commercialization, with experience raising over $300 million in equity financing and structuring international partnerships and licensing agreements in the biotechnology sector.
Investors · 1
Frequently asked questions
- What does Rnatives do?
- Develops precision RNA-based gene-regulating therapies aimed at treating serious diseases.
- Who founded Rnatives?
- Rnatives was founded by Tiia Turunen.
- Who are Rnatives's investors?
- Rnatives's investors include Nordic Science Investments.